Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
CMT Type 4
…to Type 4 include: CMT4A – Ganglioside-induced differentiation-associated protein 1 (GDAP1) CMT4B1 – Myotubularin related protein 2 (MTMR2) CMT4B2 – SET binding factor 2 (SBF2/MTMR13) CMT4B3 – SET binding factor…
CMTA Announces New Center of Excellence in Canada
…Neuropathy Consortium (INC), an international network of CMT clinical research centers supported by CMTA through the CMTA-INC partnership. Dr. Gonorazky’s CMT clinic operates within the hospital’s Neuromuscular Program and provides…
Muscular Atrophy and CMT
…neurogenic atrophy sets in with that same muscle, the atrophy becomes nonrecoverable. This is why CMT specialists and the CMTA recommends exercise for CMT patients. While exercise does not treat…
CMTA-STAR Collaboration Celebrates a Decade of CMT Genetic Discovery Through the GENESIS Database
…to the discovery of over 25 new CMT genes, including the monumental CMT-SORD discovery. Since its inception, CMTA, through the CMTA-STAR program, has been a committed partner and ongoing sponsor…
CMTA Alliance Partner, Applied Therapeutics, Announces Positive 12-Month Results in its Ongoing INSPIRE Phase III Trial for CMT-SORD
…statement, Applied Therapeutics said the trial at its 12-month mark has shown a statistically significant correlation between sorbitol levels and the prespecified CMT Functional Outcomes Measure (CMT-FOM) and that treatment…
CMTA-Funded Research Database Identifies New Mutations
…evaluate CMT therapies. “The work in Züchner’s lab aligns perfectly with the CMTA’s Strategy to Accelerate Research (STAR),” CMTA CEO Amy Gray said. “Funding this project is another way the…